Read Brent Coon's Letter the Beaumont Enterprise
Dear Beaumont Enterprise,
The Beaumont Enterprise, as one of the primary print media voices for the Southeast Texas market, has a long history of integrity and independence which is regrettably eroding with the continued inclusion of the Southeast Texas Record for regular Thursday distribution.
(READ MORE)
The Beaumont Enterprise, as one of the primary print media voices for the Southeast Texas market, has a long history of integrity and independence which is regrettably eroding with the continued inclusion of the Southeast Texas Record for regular Thursday distribution.
(READ MORE)
Read Brent Coon's Response to New York Times Op Ed on BP
Before anyone starts feeling sorry for BP in the oil spill litigation and buy off on the article written by Mr. Nocera of the New York Times, reprinted in the Enterprise last week, certain facts should be known:
FACT ONE:
The New York Times is accepting millions of dollars in BP and U.S. Chamber of Commerce advertising. Full page ads directly criticizing the BP litigation, specifically the plaintiff lawyers involved in representing claimants.
(READ MORE)
FACT ONE:
The New York Times is accepting millions of dollars in BP and U.S. Chamber of Commerce advertising. Full page ads directly criticizing the BP litigation, specifically the plaintiff lawyers involved in representing claimants.
(READ MORE)
ILR’s “Faces of Lawsuit Abuse” |
|
In 1998, The U.S. Chamber of Commerce founded a national organization called the Institute for Legal Reform (ILR). The ILR is the branch of the Chamber that spends hundreds of millions of dollars each year launching propaganda campaigns aimed at demonizing trial lawyers and the legal system.
(READ MORE)
(READ MORE)
AAJ Statement on BP’s Campaign to Evade Accountability
BP pled guilty to causing the worst environmental disaster in US history that resulted in the loss of Americans lives and American business. Now they have launched a PR campaign to evade accountability for the damage they caused and restrain continued shareholder frustration.
(READ MORE)
(READ MORE)
Supreme Court rules generic-drug makers can't be sued over defects
Americans who are badly hurt by a generic drug may not sue the drug maker for compensation, the Supreme Court ruled Monday, giving manufacturers a shield from liability for the medications taken most commonly in this country.
(READ MORE)
(READ MORE)